SCHEMBL2624934

SCHEMBL2624934

CO[C@@H]1CCCC[C@@H]1OCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.55
OPRK1 P41145 2/20 0.52
OPRD1 P41143 1/20 0.52
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MAPT P10636 1/20 0.51
PSEN1 P49768 1/20 0.48
PSEN2 P49810 1/20 0.48
APH1B Q8WW43 1/20 0.48
NCSTN Q92542 1/20 0.48
APH1A Q96BI3 1/20 0.48
PSENEN Q9NZ42 1/20 0.48
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SLC18A2 Q05940 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2624933 1.00 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL6729315 0.85 OPRM1 (0.52) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL6729317 0.85 OPRM1 (0.52) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL409827 0.83 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL410115 0.83 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL411284 0.83 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL409662 0.83 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL410620 0.80 OPRM1 (0.51) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL6722023 0.80 OPRM1 (0.55) OPRM1OPRK1OPRD1ALDH1A1KDM4E
SCHEMBL410116 0.80 OPRM1 (0.51) OPRM1OPRK1OPRD1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163938-B2 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2012-04-24 US disclosed
US-20110004006-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF CARDIOME PHARMA CORP. (CA) 2011-01-06 US disclosed
US-20070254945-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF CARDIOME PHARMA CORP. (CA) 2007-11-01 US disclosed
US-20070099983-A1 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004006-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF KCNH2, KCNC1, KCNH3 OPRM1 2058/4885OPRK1 1082/4885OPRD1 1751/4885
US-20070254945-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF KCNH2, KCNC1, KCNH3 OPRM1 2058/4885OPRK1 1082/4885OPRD1 1751/4885
US-20070099983-A1 Aminocyclohexyl ether compounds and uses thereof KCNH2, KCNC1, KCNH3 OPRM1 2058/4885OPRK1 1082/4885OPRD1 1751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.